High pancreatic-specific lipase in dogs: medicines most often reported

647 FDA reports in dogs mention high pancreatic-specific lipase. These are the medicines named most often in those reports.

Trilostane (Vetoryl)
100 0.8% of its reports
Bedinvetmab (Librela)
100 0.5% of its reports
Maropitant (Cerenia)
89 0.7% of its reports
Fluralaner (Bravecto)
77 0.1% of its reports
Oclacitinib (Apoquel)
59 0.2% of its reports
Gabapentin
57 0.6% of its reports
Grapiprant (Galliprant)
44 0.5% of its reports
Carprofen (Rimadyl)
41 0.1% of its reports
Insulin
40 0.5% of its reports
Pyrantel + Sarolaner (Simparica Trio)
40 0.1% of its reports
Moxidectin (ProHeart 6)
39 0.1% of its reports
Bordetella Vaccine
39 0.4% of its reports
Ivermectin + Pyrantel (Heartgard Plus)
34 0.0% of its reports
Afoxolaner (NexGard)
32 0.1% of its reports
Prednisone
31 0.3% of its reports
Leptospirosis Vaccine
31 0.4% of its reports
Lokivetmab (Cytopoint)
31 0.5% of its reports
Rabies Vaccine
27 0.3% of its reports
Metronidazole
26 0.8% of its reports
Enrofloxacin (Baytril)
23 0.6% of its reports
Ondansetron
21 3.2% of its reports
Dexamethasone
20 0.7% of its reports